RecruitingNot Applicable

An Observational Study of Local Relapse After High Grade Osteosarcoma

Italy150 participantsStarted 2022-06-13

Plain-language summary

multicenter retrospective and prospective study in patients with high-grade osteosarcoma

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients who experienced LR as first event of recurrence after treatment for localized high-grade osteosarcoma of bone, including cases with synchronous lung metastases * Adequate patient compliance to follow-up visits * Written informed consent prior to any study-specific analysis and/or data collection * No age limits Exclusion Criteria: * Cases of LR demonstrated after \> 3 months after metastatic disease * Impossibility to ensure adequate compliance

What they're measuring

post local relapse survival

Timeframe: 24 months follow up

Trial details

NCT IDNCT06017518

SponsorIstituto Ortopedico Rizzoli

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-06-30

Contact for this trial

Emanuela Palmerini, MD

051/6366 emanuela.palmerini@ior.it

View on ClinicalTrials.gov More Osteosarcoma trials